Related Experiment Video

Updated: Sep 28, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.3K

Characterization of Somatic Mutations That Affect Neoantigens in Non-Small Cell Lung Cancer

Hongge Liang1,2, Yan Xu1, Minjiang Chen1

  • 1Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Frontiers in Immunology
|March 31, 2022
PubMed
Abstract

Insights

Somatic mutations in non-small cell lung cancer (NSCLC) influence neoantigen numbers. Missense mutations and specific base substitutions correlate with higher neoantigen loads, impacting immunotherapy potential in NSCLC patients.

Area of Science:

  • Oncology
  • Genomics
  • Immunotherapy

Background:

  • Immune checkpoint inhibitors (ICIs) are crucial for advanced non-small cell lung cancer (NSCLC).
  • Neoantigens are key biomarkers and immunotherapy targets in NSCLC prognosis and treatment.

Purpose of the Study:

  • To characterize the relationship between somatic mutations and neoantigens in NSCLC surgical specimens.
  • To identify mutation types and characteristics associated with neoantigen burden.

Main Methods:

  • Prospective study of NSCLC surgical specimens.
  • Whole-exome sequencing of tumor and normal tissues.
  • Prediction of candidate neoantigens using generative software.

Main Results:

  • Genes with high neoantigen burden showed increased mutation types and frequencies.
  • Candidate neoantigen count correlated positively with missense mutations, insertions/deletions, split-site, and nonsense mutations.
  • Missense mutations, base transversions, and specific base transitions were significantly associated with neoantigen number.

Conclusions:

  • Neoantigen quantity in NSCLC is linked to mutation frequency, type, and base substitution patterns.
  • Understanding these relationships can refine neoantigen prediction and immunotherapy strategies for NSCLC.
Keywords:
genetic mutation characteristicsneoantigensnon-small cell lung cancertumor neoantigen burdenwhole exome sequencing

More Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.5K
Comparative Lesions Analysis Through a Targeted Sequencing Approach08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.9K

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.2K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K